paricalcitol 0.001 MG Oral Capsule
1 INDICATIONS AND USAGE Paricalcitol capsules are a vitamin D analog indicated in adults for the prevention and treatment of secondary hyperparathyroidism associated with: Chronic kidney disease (CKD) Stages 3 and 4 (1.1) . CKD Stage 5 in patients on hemodialysis or peritoneal dialysis (1.2) . 1.1 Chronic Kidney Disease Stages 3 and 4 Paricalcitol capsules are indicated in adults for the prevention and treatment of secondary hyperparathyroidism associated with Chronic Kidney Disease (CKD) Stages 3 and 4. Pediatric use information for patients 10 to 16 years of age is approved for AbbVie Inc.’s Zemplar (paricalcitol) capsules. However, due to AbbVie Inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. 1.2 Chronic Kidney Disease Stage 5 Paricalcitol capsules are indicated in adults for the prevention and treatment of secondary hyperparathyroidism associated with CKD Stage 5 in patients on hemodialysis (HD) or peritoneal dialysis (PD). Pediatric use information for patients 10 to 16 years of age is approved for AbbVie Inc.’s Zemplar (paricalcitol) capsules. However, due to AbbVie Inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
Amneal Pharmaceuticals LLC
Related Pills
paricalcitol 0.004 MG Oral Capsule
Amneal Pharmaceuticals LLC
paricalcitol 0.001 mg oral capsule
amneal pharmaceuticals llc
Amlodipine Besylate Amlodipine 2.5 MG Oral Tablet
Mylan Pharmaceuticals Inc.
Amantadine Hydrochloride 100 MG Oral Tablet
Actavis Pharma, Inc.
Progesterone 100 MG Oral Capsule
Amneal Pharmaceuticals LLC
Progesterone 200 MG Oral Capsule
Amneal Pharmaceuticals LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
PARICALCITOL capsules, 1 mcg, are supplied as oval, gray soft gelatin capsules imprinted with “A8”. They are available as follows: Bottles of 30: NDC 65162-822-03 Bottles of 90: NDC 65162-822-09
PARICALCITOL capsules, 2 mcg, are supplied as oval, brown soft gelatin capsules imprinted with “A83”. They are available as follows: Bottles of 30: NDC 65162-823-03 Bottles of 90: NDC 65162-823-09
PARICALCITOL capsules, 4 mcg, are supplied as oval, light yellow soft gelatin capsules imprinted with “A84”. They are available as follows: Bottles of 30: NDC 65162-824-03 Bottles of 90: NDC 65162-824-09 Storage Store
PARICALCITOL capsules at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
More pills like OVAL A8